{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T04:52:55Z","timestamp":1779339175922,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This prospective cohort study aims to investigate the incidence, related factors and prognosis of IgG4-related disease (IgG4-RD) with malignancies in the Chinese cohort. We prospectively analyzed the IgG4-RD patients recruited in Peking Union Medical College Hospital from January 2011 to August 2018 and identified patients diagnosed with IgG4-RD complicating malignancies. Data regarding demographics, clinical features, treatment and prognosis of IgG4-RD patients complicating malignancies were collected and compared to those of age- and sex-matched controls. Among the 587 Chinese patients with IgG4-RD, 17 malignancies were identified. Ten of them developed malignancy after the diagnosis of IgG4-RD, given a standard incidence ratio (SIR) of 2.78 (95%CI 1.33\u20135.12). Multivariate logistic analysis indicated that autoimmune pancreatitis (OR\u2009=\u20096.230, 95%CI 1.559\u201324.907, p\u2009=\u20090.010) was positively associated with malignancy, whereas eosinophilia (OR\u2009=\u20090.094, 95%CI 0.010\u20130.883, p\u2009=\u20090.039) was negatively related with malignancies. During a median follow-up period of 61.4\u2009\u00b1\u200926.4 months, all patients with IgG4-RD and malignancies survived. We conclude that an increased incidence of malignancy was found in Chinese IgG4-RD cohort. Autoimmune pancreatitis is a potential risk factor, whereas eosinophilia is a possible protective factor for complicating malignancies.<\/jats:p>","DOI":"10.1038\/s41598-020-61585-z","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T12:46:08Z","timestamp":1584535568000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Malignancy and IgG4-related disease: the incidence, related factors and prognosis from a prospective cohort study in China"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8099-6562","authenticated-orcid":false,"given":"Hanqi","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6811-0255","authenticated-orcid":false,"given":"Huaxia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panpan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shangzhu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiuliang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linyi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunyun","family":"Fei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8775-1699","authenticated-orcid":false,"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengchun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,18]]},"reference":[{"key":"61585_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","volume":"22","author":"H Umehara","year":"2012","unstructured":"Umehara, H. et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod. Rheumatol. 22, 21\u201330 (2012).","journal-title":"Mod. Rheumatol."},{"key":"61585_CR2","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/S2665-9913(19)30017-7","volume":"1","author":"W Zhang","year":"2019","unstructured":"Zhang, W. & Stone, J. H. Management of IgG4-related disease. Lancet Rheumatol. 1, e55\u2013e65 (2019).","journal-title":"Lancet Rheumatol."},{"key":"61585_CR3","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/1756-185X.13093","volume":"20","author":"SS Ahn","year":"2017","unstructured":"Ahn, S. S., Song, J. J., Park, Y.-B. & Lee, S.-W. Malignancies in Korean patients with immunoglobulin G4-related disease. Int. J. Rheum. Dis. 20, 1028\u20131035 (2017).","journal-title":"Int. J. Rheum. Dis."},{"key":"61585_CR4","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1002\/art.39686","volume":"68","author":"H Sekiguchi","year":"2016","unstructured":"Sekiguchi, H. et al. IgG4-Related Disease: Retrospective Analysis of One Hundred Sixty-Six Patients. Arthritis Rheumatol. 68, 2290\u20132299 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"61585_CR5","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1002\/art.39773","volume":"68","author":"ZS Wallace","year":"2016","unstructured":"Wallace, Z. S., Wallace, C. J., Lu, N., Choi, H. K. & Stone, J. H. Association of IgG4-Related Disease With History of Malignancy. Arthritis Rheumatol. 68, 2283\u20132289 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"61585_CR6","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.3899\/jrheum.150436","volume":"42","author":"J Asano","year":"2015","unstructured":"Asano, J. et al. Association Between Immunoglobulin G4-related Disease and Malignancy within 12 Years after Diagnosis: An Analysis after Longterm Followup. J. Rheumatol. 42, 2135\u20132142 (2015).","journal-title":"J. Rheumatol."},{"key":"61585_CR7","doi-asserted-by":"publisher","first-page":"e680","DOI":"10.1097\/MD.0000000000000680","volume":"94","author":"D Inoue","year":"2015","unstructured":"Inoue, D. et al. IgG4-related disease: dataset of 235 consecutive patients. Med. 94, e680 (2015).","journal-title":"Med."},{"key":"61585_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2169\/internalmedicine.53.1342","volume":"53","author":"K Hirano","year":"2014","unstructured":"Hirano, K. et al. Incidence of malignancies in patients with IgG4-related disease. Intern. Med. 53, 171\u2013176 (2014).","journal-title":"Intern. Med."},{"key":"61585_CR9","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3109\/s10165-011-0520-x","volume":"22","author":"M Yamamoto","year":"2012","unstructured":"Yamamoto, M. et al. Risk of malignancies in IgG4-related disease. Mod. Rheumatol. 22, 414\u2013418 (2012).","journal-title":"Mod. Rheumatol."},{"key":"61585_CR10","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1038\/ajg.2014.223","volume":"109","author":"MT Huggett","year":"2014","unstructured":"Huggett, M. T. et al. Type 1 Autoimmune Pancreatitis and IgG4-Related Sclerosing Cholangitis Is Associated With Extrapancreatic Organ Failure, Malignancy, and Mortality in a Prospective UK Cohort. Am. J. Gastroenterology 109, 1675\u20131683 (2014).","journal-title":"Am. J. Gastroenterology"},{"key":"61585_CR11","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1093\/rheumatology\/kev203","volume":"54","author":"W Lin","year":"2015","unstructured":"Lin, W. et al. Clinical characteristics of immunoglobulin G4\u2013related disease: a prospective study of 118 Chinese patients. Rheumatol. 54, 1982\u20131990 (2015).","journal-title":"Rheumatol."},{"key":"61585_CR12","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1093\/rheumatology\/key397","volume":"58","author":"L Wang","year":"2018","unstructured":"Wang, L. et al. Sex disparities in clinical characteristics and prognosis of immunoglobulin G4\u2013related disease: a prospective study of 403 patients. Rheumatol. 58, 820\u2013830 (2018).","journal-title":"Rheumatol."},{"key":"61585_CR13","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1007\/s00259-014-2729-3","volume":"41","author":"J Zhang","year":"2014","unstructured":"Zhang, J. et al. Characterizing IgG4-related disease with 18F-FDG PET\/CT: a prospective cohort study. Eur. J. Nucl. Med. Mol. Imaging 41, 1624\u20131634 (2014).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"61585_CR14","doi-asserted-by":"publisher","first-page":"e579","DOI":"10.1097\/MD.0000000000000579","volume":"94","author":"C Deng","year":"2015","unstructured":"Deng, C. et al. Histopathological diagnostic value of the IgG4+\/IgG+ ratio of plasmacytic infiltration for IgG4-related diseases: a PRISMA-compliant systematic review and meta-analysis. Med. 94, e579 (2015).","journal-title":"Med."},{"key":"61585_CR15","first-page":"502","volume":"34","author":"W Chen","year":"2015","unstructured":"Chen, W., Zheng, R., Zeng, H. & Zhang, S. The updated incidences and mortalities of major cancers in China, 2011. Chin. J. Cancer 34, 502\u2013507 (2015).","journal-title":"Chin. J. Cancer"},{"issue":"1","key":"61585_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s40880-017-0234-3","volume":"36","author":"R Zheng","year":"2017","unstructured":"Zheng, R. et al. Estimates of cancer incidence and mortality in China, 2013[J]. Chin. J. Cancer 36(1), 66 (2017).","journal-title":"Chin. J. Cancer"},{"key":"61585_CR17","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/ajg.2012.465","volume":"108","author":"M Shiokawa","year":"2013","unstructured":"Shiokawa, M. et al. Risk of cancer in patients with autoimmune pancreatitis. Am. J. Gastroenterology 108, 610\u2013617 (2013).","journal-title":"Am. J. Gastroenterology"},{"key":"61585_CR18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/MPA.0000000000000053","volume":"43","author":"PA Hart","year":"2014","unstructured":"Hart, P. A. et al. Risk of cancer in autoimmune pancreatitis: a case-control study and review of the literature. Pancreas 43, 417\u2013421 (2014).","journal-title":"Pancreas"},{"key":"61585_CR19","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000455963","volume":"95","author":"A Schneider","year":"2017","unstructured":"Schneider, A. et al. Risk of Cancer in Patients with Autoimmune Pancreatitis: A Single-Center Experience from Germany. Digestion 95, 172\u2013180 (2017).","journal-title":"Digestion"},{"key":"61585_CR20","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1038\/ajg.2014.223","volume":"109","author":"M Huggett","year":"2014","unstructured":"Huggett, M. et al. Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extra-pancreatic organ failure, malignancy and mortality in a prospective UK cohort. Am. J. Gastroenterol. 109, 1675\u201383 (2014).","journal-title":"Am. J. Gastroenterol."},{"key":"61585_CR21","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00535-010-0211-y","volume":"45","author":"T Kamisawa","year":"2010","unstructured":"Kamisawa, T. et al. K-ras mutation in the major duodenal papilla and gastric and colonic mucosa in patients with autoimmune pancreatitis. J. Gastroenterol. 45, 771\u2013778 (2010).","journal-title":"J. Gastroenterol."},{"key":"61585_CR22","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.ccm.2019.05.005","volume":"40","author":"ZSWM MSc","year":"2019","unstructured":"MSc, Z. S. W. M. et al. Immunoglobulin G4-related Disease. Clin. Chest Med. 40, 583\u2013597 (2019).","journal-title":"Clin. Chest Med."},{"key":"61585_CR23","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1093\/rheumatology\/kev438","volume":"55","author":"ZS Wallace","year":"2016","unstructured":"Wallace, Z. S. et al. Predictors of disease relapse in IgG4-related disease following rituximab. Rheumatol. 55, 1000\u20131008 (2016).","journal-title":"Rheumatol."},{"key":"61585_CR24","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.cgh.2017.02.007","volume":"15","author":"EL Culver","year":"2017","unstructured":"Culver, E. L. et al. Increases in IgE, Eosinophils, and Mast Cells Can be Used in Diagnosis and to Predict Relapse of IgG4-Related Disease. Clin. Gastroenterology Hepatology 15, 1444\u20131452.e6 (2017).","journal-title":"Clin. Gastroenterology Hepatology"},{"key":"61585_CR25","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/MPA.0b013e31826bef91","volume":"42","author":"R Gupta","year":"2013","unstructured":"Gupta, R. et al. Does autoimmune pancreatitis increase the risk of pancreatic carcinoma?: a retrospective analysis of pancreatic resections. Pancreas 42, 506\u2013510 (2013).","journal-title":"Pancreas"},{"key":"61585_CR26","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1111\/j.1572-0241.2007.01264.x","volume":"102","author":"A Ghazale","year":"2007","unstructured":"Ghazale, A. et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am. J. Gastroenterology 102, 1646\u20131653 (2007).","journal-title":"Am. J. Gastroenterology"},{"key":"61585_CR27","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1053\/j.gastro.2012.07.009","volume":"143","author":"T Chiba","year":"2012","unstructured":"Chiba, T., Marusawa, H. & Ushijima, T. Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation. Gastroenterology 143, 550\u2013563 (2012).","journal-title":"Gastroenterology"},{"key":"61585_CR28","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.semarthrit.2013.04.004","volume":"43","author":"JG Routsias","year":"2013","unstructured":"Routsias, J. G. et al. Malignant lymphoma in primary Sj\u00f6gren\u2019s syndrome_ An update on the pathogenesis and treatment. Semin. Arthritis Rheumatism 43, 178\u2013186 (2013).","journal-title":"Semin. Arthritis Rheumatism"},{"key":"61585_CR29","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s12328-014-0486-2","volume":"7","author":"K Hirano","year":"2014","unstructured":"Hirano, K., Isayama, H., Tada, M. & Koike, K. Association between autoimmune pancreatitis and malignancy. Clin. J. Gastroenterol. 7, 200\u2013204 (2014).","journal-title":"Clin. J. Gastroenterol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61585-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61585-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61585-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T08:46:56Z","timestamp":1670316416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61585-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,18]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["61585"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-61585-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,18]]},"assertion":[{"value":"20 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4910"}}